Search clinical trials for: anti-PD1

Total 97100 results

University Hospital, Bordeaux

Completed

Causality of Poisoning of the Elderly: Prospective Study Based on Data From the Poison Control Centre of Bordeaux (GERIATOX)

Intoxication

France
Kamada, Ltd.

Completed

Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19

Pneumonia, Viral | Covid19

Israel
Peking Union Medical College Hospital

Recruiting

Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC

Hepatocellular Carcinoma

China
Xuanwu Hospital, Beijing

Recruiting

A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy

Immunotherapy | ADR

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC (RAIC)

Rectal Neoplasms

China
Peking University Cancer Hospital & Institute

Not yet recruiting

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC

HCC | Regorafenib | Transarterial Chemoembolization | Hepatic Arterial Infusion Chemotherapy
VA Office of Research and Development
Wayne State University; University of Michigan; Barbara Ann Karmanos Cancer Institute

Completed

Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy

Non-Small Cell Lung Cancer | Immunotherapy

United States
University Hospital Dubrava

Completed

The Anti-inflammatory Effect of Anesthetics in Abdominal Surgery

Colorectal Cancer

Croatia
Tetraphase Pharmaceuticals, Inc.
Department of Health and Human Services

Completed

Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women (BAL)

Normal Drug Tolerance

United States
Humanis Saglık Anonim Sirketi

Completed

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

Anthelmintic Agent

Jordan
Pierre Fabre Dermo Cosmetique

Completed

Clinical and Biological Anti-aging Efficacy of a Cosmetic Cream

Anti-aging

France
Assistance Publique - Hôpitaux de Paris

Completed

Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn (RAGIIF)

Anti-integrases

France
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Infusion of PD1/PDL1 Inhibitor Via Hepatic Arterial Versus Vein for Immunotherapy of Advanced Hepatocellular Carcinoma

Liver Cancer

China
Peking University Third Hospital

Recruiting

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

Proliferative Diabetic Retinopathy

China
Emory University
National Cancer Institute (NCI)

Completed

FACBC Outcomes for Post Prostatectomy

Prostate Cancer

United States
Northwestern University

Completed

Consumer Knowledge, Attitude, and Behavior Towards Aging Skin

Dermatology

United States
Isfahan University of Medical Sciences

Recruiting

Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation

Anti Aging

Iran, Islamic Republic of
Cosmetique Active International

Completed

Anti-aging Repairing Serum: Efficacy and Tolerability Study

Anti-aging

Brazil
EuroPharma, Inc.
Botalys SA

Completed

Ginseng HRG80 in Stress and Fatigue

Psychological Stress

Armenia
Revision Skincare

Completed

A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+

Photoaging | Anti-aging

United States
RenJi Hospital

Completed

Antihypertensives in Non-cardiac Surgical Population

Perioperative Antihypertensive

China
Beckman Coulter, Inc.

Completed

Clinical Performance Evaluation of AMH Assay

Anti-Mullerian Hormone

Canada, United States
Anaveon AG

Recruiting

A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

Advanced Solid Tumor | Metastatic Melanoma | Melanoma (Skin) | Cutaneous Melanoma | Adult Disease

United States, Spain, Germany, France, Italy
Bristol-Myers Squibb

Completed

A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors

CANCER,NOS

France, Canada, United States, Switzerland, Spain, Italy
Ningbo Cancer Hospital

Unknown

PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor

Advanced Malignancies | PD-1 Antibody | CAR-T Cells

China
Imugene Limited

Active, not recruiting

A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Squamous Non-small-cell Lung Cancer | Large Cell Carcinoma Lung | Adenocarcinoma Lung

United States, Australia
Anhui Provincial Hospital

Not yet recruiting

The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT

High Titers of Anti-HLA Antibody (MFI ≥5000)

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Methylphenidate and Physical Activity to Reduce Cancer Related Fatigue Due to Anti PD1 Immunotherapy

Metastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm

United States
Oslo University Hospital
Merck Sharp & Dohme LLC; Norwegian Cancer Society

Completed

Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma (Lymvac-2)

Follicular Lymphoma

Norway
Lars Peter Holst Andersen
University of Copenhagen

Completed

The Analgesic Effects of Melatonin

Analgesia | Antihyperalgesia

Denmark
Ningbo No. 1 Hospital
Zhejiang University

Recruiting

CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL

Diffuse Large B-cell Lymphoma

China
University of Cologne

Recruiting

Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy (AERN)

Classical Hodgkin Lymphoma

Germany
Sun Yat-sen University

Unknown

A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer

Colorectal Cancer Stage III

China
Jason J. Luke, MD
Bristol-Myers Squibb

Recruiting

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors

Melanoma | Carcinoma, Renal Cell | Unresectable Solid Tumors

United States
National Cancer Institute (NCI)

Completed

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Cholangiocarcinoma | Bile Duct Cancer | Biliary Tract Neoplasms | Liver Cancer | Gallbladder Cancer

United States
Databean
Octapharma

Terminated

A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients (DSA)

Renal Transplant Recipients With Anti-HLA Antibodies

United States
National Cancer Institute (NCI)

Completed

AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer

Colorectal Neoplasms | Colorectal Cancer | Colorectal Carcinoma

United States
Kingman Regional Medical Center

Completed

Prevalence of COVID-19 Antibodies Kingman AZ

Covid19

United States
China Medical University, China

Withdrawn

Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects

Antishivering Effects

China
Clinique Ovo

Terminated

Anti-Mullerian Hormone Levels Before and After an Open Myomectomy

Anti-Mullerian Hormone

Canada
Janssen Research & Development, LLC

Completed

Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone

Immunoassay | Antipsychotic

Belgium
Assistance Publique - Hôpitaux de Paris

Recruiting

Current Use in Intensive Care Units by Intensivists of Antihypertensive Drugs (CUICUI-AHD)

Antihypertensive Drugs in ICU

France
Bristol-Myers Squibb

Active, not recruiting

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

Neoplasms by Site

United States, Australia, Denmark, France, Switzerland, Austria, Canada, Germany, Japan, Netherlands, Norway, Spain, United Kingdom, Finland, Italy
Sun Yat-sen University

Recruiting

Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial

Nasopharyngeal Carcinoma

China
University Hospital, Ghent
GZA Ziekenhuizen Campus Sint-Augustinus

Completed

A Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma.

Melanoma

Belgium
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Use of QTRAC Technique to Measure Axonal Excitability in Anti-MAG Neuropathy (EXCIMAG)

Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)

France
Daniela Matei, MD
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network

Completed

Pembro/Carbo/Taxol in Endometrial Cancer

Endometrial Cancer | Endometrial Adenocarcinoma

United States
University Hospital Tuebingen

Recruiting

Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26) (IT-PD1)

Leptomeningeal Disease

Germany
Chiang Mai University

Completed

Appropriateness of Intravenous Antibiotics Prescriptions at Hospital Discharge

Anti-Infectives Adverse Reaction

Thailand
Cardiovascular Academy Society, Turkey

Completed

Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey

Anti-platelet Therapy

Turkey

Search clinical trials for: anti-PD1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations